Introduction
The story of the nojirimycins begins with the isolation of nojirimycin (1, Fig. 1 ) in 1966 by Inuoye et al. from several strains of Streptomyces. 1 This highly polar "heterosugar" was first identified as an antibiotic and later recognized as a glucosidase inhibitor. 2 In 1976, Bayer chemists discovered that the stable, naturally occuring 1-deoxynojirimycin (2, originally synthesized in 1966 by Paulsen et al. 3 ) is a potent a-glucosidase inhibitor. Since these seminal discoveries nojirimycins have attracted a great deal of attention both from the academia 4 as well as the pharma industry. Two derivatives of 2 are currently in the market for the treatment of two different human conditions. The inhibitory power of 2 is being realized in miglitol (Glyset R , 3), a drug for treating type II diabetes mellitus. 5 The drug effectively lowers blood sugar levels by inhibiting the break down of dietary sugars. On the other hand, N-butyl-DNJ (Zavesca R , 4) is being used for the treatment of Gaucher disease, a serious lysosomal storage disorder previously only treatable through enzyme replacement therapy. 6 Zavesca R inhibits the biosynthesis of glycosphingolipids, thereby decreasing their accumulation in the body. Besides these two targets, inhibition of several other enzymes have been or are being investigated, † Electronic Supplementary Information (ESI) available: Copies of 1 H and 13 C spectra are included in the ESI. See DOI: 10.1039/c0ob00747a/ including glycosyl transferases, 7 glycogen phosphorylase, 8 sugar nucleoside mutase 9 and metalloproteinases. 10 Zavesca R has also shown some promise as a male contraceptive. 11 Iminosugar derivatives have been reported to be active against the Flaviviridae viral family, 12 cytotoxic against several cancer cell lines 13 and to inhibit angiogenesis. 14 Hence the need to be able to produce practical amounts of nojirimycin analogues with varying stereochemical configurations is apparent. Herein we wish to describe a practical route to (-)-1-deoxyaltronojirimycin (5); a nojirimycin analogue having altrose stereochemistry. 15 The compound itself shows modest activity towards glycosidases, 16 however it serves as a proof-of-concept towards derivatives having such stereochemistry.
Results and discussion
Due to the high interest the synthetic community has had in these so called azasugars, many imaginative synthetic routes have been deviced. Nojirimycins and derivatives thereof have been accessed for example from carbohydrates, amino acids and tartaric acid. 17 Our laboratory has had a long term interest in diastereoselective synthesis of enantiopure (vicinal) amino alcohols from amino acids. Previously we described the diastereoselective synthesis of (-)-1-deoxygalactonojirimycin (DGJ, 6) using the general strategy outlined in Scheme 1. 18 Disconnection along the C1-N bond gives rise to an open-chain compound 8 with a leaving group at C1. This can be thought to be derived from the differentially protected bis-allylic alcohol 9. This is in turn accesible from Garner's aldehyde (10) and a protected propargyl alcohol 11 via formal reductive coupling. We have successfully accessed Scheme 1 General retrosynthetic strategy.
allylic alcohols such as 9 through Horner-Wadsworth-Emmons reaction between an amino acid derived b-keto phosphonate and the corresponding aldehyde followed by diastereoselective reduction. 19 However, we noted that the diastereoselectivity of the reduction is highly sensitive to the actual substrate, and more importantly partial racemization of the phosphonate becomes a problem in large scale synthesis. To overcome this problem, we have used a zinc nucleophile generated by hydrozirconationtransmetallation sequence to couple (-)-10 and 12 with exceptional syn (>20 : 1) selectivity (Scheme 2). 20 Now we wanted to be able to access the anti relationship between the C4 and C5 substituents. This would in turn call for reversal of diastereoselectivity in the coupling step. Despite a promising literature precedent, we were not able to reverse the diastereoselectivity. 21 Instead, we turned our attention to lithiated nucleophiles, as it is known that their addition to 10 proceeds with anti preference.
Scheme 2 Key reductive coupling.
The synthesis commenced with the addition of lithiated 12 to the (-)-Garner aldehyde (Scheme 3). 22 We found out that if performed in THF, the addition proceeded smoothly and in useful diastereomeric ratio (>15 : 1). No difference in diasteremeric ratio was detected in the presence of HMPA. We then envisioned that reduction of the triple bond with Red-Al would deliver the anti congener of 13. Instead a mixture of 15 and the allene 16 was produced as evidenced by the high carbon shift at d = 207.9 ppm. 23 Under no conditions could the undesired elimination of TBSO be supressed. In order to avoid problems in the reduction step, we protected the secondary alcohol of 14 as the benzyl ether 24 (Scheme 4) followed by desilylation of the primary alcohol. NH 4 F·HF proved to be a far superior desilylation reagent compared to the standard TBAF (tetrabutylammonium fluoride) both in terms of price and practicality, as no hard to remove tetrabutyl ammonium residues are formed in the reaction. In fact, simple silica gel filtration after the desilylation was to provide 17 in more than adequate purity. Treatment of 17 with 2 equivalents of Red-Al produced exclusively the desired trans-allylic alcohol 18 in near quantitative yield, again without any need to resort to chromatography. Osmium catalyzed dihydroxylation under modified Upjohn conditions provided the tetraol 19 in 81% yield (6 : 1 dr 25 ). 26 The diastereomeric mixture proved to be extremely difficult to purify. One of the diasteremers is a good ligand for osmium as the black Os(VI) was still present even after three chromatographic runs. Nevertheless, adequate amounts of pure 19 could be produced through this route for further experiments.
Attempted mesylation of the primary alcohol only led to decomposition upon isolation. On the other hand, the tosylate 20 was found to be relatively stable. Our first attempt (TsCl, NEt 3 , CH 2 Cl 2 ) delivered the tosylate in meager 35% yield. In an effort to improve the yield, we tried numerous bases and conditions ( Table 1 ). Increasing the temperature significantly improved the yield (entry 2). Added secondary base (DMAP) did not improve the yield, on the contrary significant decomposition was evident (entry 3). We also attempted to catalyze the reaction with dibutyl tinoxide as reported. 27 However, the substrate proved to be reluctant to such catalysis (entries 4 and 5). We then proceeded to test several other bases, of which N-methyl imidazole proved to be the best, delivering the desired monotosylate 20 in 67-76% yield. It should be noted, that under no conditions we detected any bistosylated products.
With every functionality in place we were now ready for the ring closure. Removal of the N,O-acetal and the BOC-group was accomplished with hydrochloric acid in methanol in quantitative yield. The cyclization was effected by treating the crude salt with calcium carbonate in methanol, yielding the piperidine 21 in 68% yield after chromatography. If the cyclization was effected using triethyl amine or diisopropylethyl amine the crude reaction mixture was difficult to purify due to the oily amine salts. Hydrogenolysis of the remaining protecting group under acidic conditions delivered 5·HCl in quantitative yield, thereby completing the synthesis in 32% overall yield over 9 steps. However, we were not satisfied with the hard-to-purify dihydroxylation production 19, nor with the low yielding tosylation step. To this end another leaving group was envisioned. Allylic chlorination of 18 delivered the chloride 22 in good yield (88%) with no need for chromatographic purification (Scheme 5). Subsequent dihydroxylation delivered 23 in passable yield (81%) and without erosion of the diastereomeric ratio (6 : 1). Moreover, the diastereomers were now much easier to separate due to lack of the primary hydroxyl group. The dihydroxylation was also attempted using KMnO 4 . Without buffering (CH 2 Cl 2 , 1.5 equivalents of KMnO 4 ) no reaction took place, however when buffered with NaHCO 3 complete decomposition was observed. Deprotection and cyclization worked with similar efficiency compared to the tosylate (78%, 2 steps). After hydrogenolysis of the benzyl protection, (-)-altroDNJ hydrocloride (-)-5 was obtained in improved 43% overall yield. Furthermore one chromatographic purification was omitted. Scheme 5 Improved endgame.
Conclusions
Herein we have desribed a method for producing (-)-altroDNJ hydrochloride in 9 steps with 43% overall yield. Only two chromatographic purifications in the late stages are required, making the route fast and efficient.
Experimental section
Dichloromethane and tetrahydrofuran were obtained from a solvent drier (MB SPS-800, neutral alumina). Methanol was distilled from Mg(OMe) 2 . Dimethyl formamide was distilled from molecular sieves (5 Å ) and ninhydrin. Other solvents used in reactions and in chromatography were of p.a. quality. Reagents were obtained from Sigma-Aldrich or from Acros Organics and used as such, unless otherwise stated. TLC monitoring was performed on Merck silica gel 60 F 254 (230-400 mesh, aluminium) plates. Stains used to visualize the plates were permanganate (3 g KMnO 4 , 20 g K 2 CO 3 , 5 mL 1 M NaOH, diluted to 300 mL with water), vanillin (3 g vanillin, 2.5 mL conc. H 2 SO 4 , 1.5 mL acetic acid, 125 mL EtOH) and UV-light (l = 254 nm). Flash chromatography was performed on Merck Silica Gel 60 silica. The celite used in filtrations was either Fluka Celite 501 or Sigma-Aldrich Celite 535 Coarse. NMR spectra were recorded on Bruker Avance 400 spectrometer. The spectra were calibrated either to TMS ( 1 H: d 0.00 ppm), MeOD ( 1 H: d 3.34 ppm, 13 
tert-Butyldimethyl(prop-2-ynyloxy)silane (12)
To a solution of propargyl alcohol (1.00 g, 17.8 mmol, 100 mol%) in dry dichloromethane (7 mL) under argon was added tertbutyldimethylsilyl chloride (2.68 g, 17.8 mmol, 100 mol%) followed by imidazole (2.43 g, 35.7 mmol, 200 mol%). The flask was equipped with a condenser after which the solution was heated to reflux. After 2 h the starting material was consumed by TLC and the flask was allowed to cool to room temperature. The reaction was quenched with 10 mL of ice-cold water. The resulting mixture was filtered through a pad of celite. The filtrate was transferred to a separating funnel and the phases were separated. The aqueous phase was extracted 3 ¥ 10 mL CH 2 Cl 2 . Combined organic phases were washed with brine (25 mL), dried over Na 2 SO 4 A flask under argon was charged with the crude product from the previous reaction (42.3 g, assumed circa 98.0 mmol, 100 mol%), and dry DMF (100 mL). The solution was cooled to 0 • C and benzyl bromide (15.4 mL, 130 mmol, 130 mol%) was added together with KI (830 mg, 5 mmol, 5 mol%). Finally sodium hydride (4.8 g, 120 mmol, 120 mol%, 60% dispersion in mineral oil) was added as a single portion. After the gas evolution had stopped the slurry was diluted with 100 mL of dry THF. After 1 h of stirring, the reaction was quenched by adding 60 mL of sat. NaHCO 3 (dropwise at first, until gas no longer forms) and then diluted with 150 mL of water. The mixture was extracted with EtOAc (3 ¥ 100 mL). The combined organic phases were washed with water (200 mL) and brine, dried over Na 2 SO 4 and concentrated. The residue was filtered through a pad of silica gel (eluted with 5% EtOAc/Hexanes) to yield 52.4 g of light yellow oil. Analytical sample was prepared by flash column chromatography (5% Ethyl acetate/hexanes). The product from the previous reaction (52.8 g, assumed circa 98 mmol, 100 mol%) was dissolved in MeOH (80 mL) under ambient conditions. NH 4 HF·HF (11.5 g, 200 mmol, 200 mol%) was added and the resulting mixture was stirred for 18 h. To quench the reaction, 30 g of silica gel was added to the reaction mixture. After 30 min of stirring, the solution was diluted with 350 mL of CH 2 Cl 2 , passed through a pad of silica (washed with 10% MeOH-CH 2 Cl 2 ) and concentrated. The crude product was dissolved in 20% EtOAc/Hexanes and filtered through a pad of silica. After concentration 34.0 g (91% over 3 steps) of pale yellow oil was obtained. Analytical sample was obtained by chromatographic purification (20% → 30% → 50% EtOAc/Hexanes 4-((R,E)-1-(benzyloxy)-4-hydroxybut-2-en-1-yl) 
-2,2-dimethyloxazolidine-3-carboxylate (18)
A flame-dried flask under argon charged with compound 17 (3.40 g, 9. 10 mmol, 100 mol%) and dry THF (45 mL) was placed in an ice/water bath. Then Red-Al was added dropwise (5.55 mL, 18.2 mmol, 65 w-% in tol.). After 15 min of stirring, the reaction was quenched by dropwise addition of MeOH (1 mL, until no further gas evolution occurs). Then 5 g of Rochelle's Salt was added followed by 5 mL of sat. aq. rochelle's salt. After 30 min of stirring the mixture was filtered through a pad of celite (filter cake was washed with 3 ¥ 30 mL of methylene chloride) and concentrated. The crude residue was dissolved in methylene chloride and filtered through a pad of silica gel (washed with 50% EtOAc/Hexanes). After concentration 3.43 g (99%) of colorless oil was obtained. ((1S,2R,3S)-1-(benzyloxy)-2,3,4 
trihydroxybutyl)-2,2-dimethyloxazolidine-3-carboxylate (19)
To a solution of 18 (2.28 g, 6.06 mmol, 100 mol%) and citric acid 
(S)-tert-butyl 4-((1S,2R,3S)-1-(benzyloxy)-2,3-dihydroxy-4-(tosyloxy)butyl)-2,2-dimethyloxazolidine-3-carboxylate (20)
To a stirred solution of 19 (540 mg, 1.33 mmol, 100 mol%) and p-toluenesulfonylchloride (280 mg, 1.46 mmol, 110 mol%) in dry CH 2 Cl 2 (6 mL) under argon was added N-methyl imidazole (250 mL, 2.13 mmol, 150 mol%) at 0 • C. After 4 h of stirring the reaction was quenched with water (10 mL). Aqueous phase was extracted 3 ¥ 5 mL CH 2 Cl 2 . Combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. Chromatographic purification (EtOAc-CH To an ice-cold solution of the crude from previous reaction (420 mg, 0.85 mmol, 100 mol%) in MeOH (8 mL) was added calcium carbonate (295 mg, 2.13 mmol, 250 mol%) and the resulting mixture was stirred for 3 h at 0 • C. The ice-cold solution was then filtered through a pad of celite (filter cake was washed 2 ¥ 1 mL ice-cold MeOH) and concentrated to yield 550 mg of slightly yellow sticky solid. Chromatographic purification (20% MeOH-CHCl 3 + 1% aq. ammonia (25%)) yielded 204 mg (69%, over 2 steps) of the title compound. 
(S)-tert-butyl 4-((R,E)-1-(benzyloxy)-4-chlorobut-2-en-1-yl)-2,2dimethyloxazolidine-3-carboxylate (22)
A flame-dried flask was charged with 18 (3.05 g, 8.08 mmol, 100 mol%), dry DMF (60 mL) and then cooled to 0 • C. POCl 3 (1.63 mL, 17.8 mmol, 220 mol%) was added as a single portion. The cooling bath was removed and the solution was stirred for 3 h. The previously colorless solution had taken a bright yellow color. The reaction was quenched by adding sat. NaHCO 3 (25 mL) dropwise at 0 • C. The mixture was diluted with water 120 mL and extracted 3 ¥ 80 mL of Et 2 O. Combined organic phases were dried over Na 2 SO 4 and concentrated. The yellow residue was dissolved in 20% EtOAc/hexanes and filtered through a pad of silica gel. After concentration 2.82 g (88%) of slightly yellow oil was obtained. ((1S,2R,3R)-1-(benzyloxy)-4-chloro-2,3 
dihydroxybutyl)-2,2-dimethyloxazolidine-3-carboxylate (23)
To a stirred solution of 2 (2.79 g, 7.39 mmol, 100 mol%) in acetone/H 2 O (8 : 1, 40 mL) was added citric acid (2.49 g, 12.93 mmol, 175 mol%) followed by OsO 4 (0.94 mL, 0.15 mmol, 2 mol%, 4 w-% in H 2 O). After the addition of osmium, the solution changed to yellow/green in color. Finally N-methyl morpholine N-oxide (1.1 g, 8.13 mmol, 110 mol%) was added and the flask was sealed with a cap. After 18 h of stirring the color had changed to bright yellow. To quench the reaction 470 mg of sodium thiosulfate was added. In 5 min black precipitate had formed. Acetone was evaporated under reduced pressure and the residue was dissolved in 35 mL of water. The aqueous mixture was extracted with EtOAc (3 ¥ 25 mL). Combined organic phases were dried over Na 2 SO 4 and concentrated to give 2.84 g of foamy glass-like product. Chromatographic purification (30% → 50% → 60% EtOAc/Hex) yielded 2.08 g (65%) of pure 23 and 390 mg of mixed 23 and 2,3-epi-23. Combined yield 2.47 g (81%), 6 : 1 dr (by NMR). To a flask charged with 23 (560 mg, 1.3 mmol, 100 mol%) was added ice-cold, freshly prepared HCl(g)/MeOH (10 mL). The solution was stirred at room temperature for 40 min and then heated gently to 50 • C. After further 40 min of stirring the starting material was consumed by TLC, and the previously colorless solution had turned yellow. Solvent was evaporated to yield 430 mg of yellow glass-like gel. The residue was then dissolved in methanol (12 mL) and the ion exchange resin was added (Merck ionenaustaucher II, 500 mg). The mixture was heated to 50 • C and stirred for 16 h. The reaction was not complete by TLC, so 200 mg more of the resin was added and stirred for further 5 h at reflux. The mixture was filtered through a fritted funnel and concentrated. The crude product was purified by flash chromatography (20% MeOH-CHCl 3 + 1% NH 4 OH [25%]) to yield 258 mg of slightly yellow oil (78%) which solidifies into a gummy solid on standing. Spectroscopically identical to one prepared from 20.
(-)-1-Deoxyaltronojirimycin hydrochloride ((-)-5 HCl)
To a stirred solution of 21 (125 mg, 0.494 mmol, 100 mol%) in MeOH (5 mL) and conc. HCl (100 mL, 1.00 mmol, 200 mol%) was added Pd/C (100 mg, 0.05 mmol, 10 mol%, 5% in Pd). H 2 atmosphere was then introduced and the solution was vigorously stirred for 1 h. The mixture was filtered through a pad of celite and concentrated to yield 106 mg (100%) of the title compound as white foam. 
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